Daytime PaO2 in OSAS, COPD and the combination of the two (overlap syndrome)

D. Lacedonia, G. E. Carpagnano, M. Aliani, R. Sabato, M. P. Foschino Barbaro, A. Spanevello, M. Carone, F. Fanfulla

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: OSAS and COPD are often associated with day-time hypoxemia. Overlap Syndrome (OS), the association between both diseases, increases the risk of day-time hypoxemia. The aim of this study was to investigate the mechanisms which could justify the low oxygen level and the effect of CPAP. Methods: We performed a retrospective analysis in all patients referred to our institutes for suspected OSAS and who also underwent spirometry and blood gas analysis during our evaluation. Thus, 720 patients were selected. According to pulmonary function test parameters they were divided into 3 groups: OSAS (N = 466,65%); OS (N = 168,23%) and COPD (N = 86,12%). In order to evaluate the differences between the three groups, ANOVA analyses were carried out, whereas a multivariate analysis was performed in order to evaluate which factors determine the diurnal PaO2. In 90 patients we also have the data on blood gas analysis after one year of CPAP treatment, so we evaluate the PaO2 improvement in accordance with compliance to treatment in these patient subgroups. Results: The OS group showed a lower level of daytime PaO2 compared with OSAS patients and T90 was higher in OS compared with OSAS. A multivariate analysis showed that in the OS diurnal PaO2 correlated with age (β = -0.20) and moreover with FEV1 (β = 0.31) and T90 (β = 0.37), while in the OSAS a correlation was found with FEV 1 (β = -0.11) and mostly with BMI (β = 0.25), age and T90. In all patients with good compliance to CPAP day-time PaO2 improved. Conclusions: Our data suggest that day-time hypoxemia in OSA patients is largely determined by the increase of body weight and severity of nocturnal hypoxia. However, CPAP therapy has been shown to improve daytime PaO2 values both in OSAS and in OS.

Original languageEnglish
Pages (from-to)310-316
Number of pages7
JournalRespiratory Medicine
Volume107
Issue number2
DOIs
Publication statusPublished - Feb 2013

Fingerprint

Chronic Obstructive Pulmonary Disease
Blood Gas Analysis
Multivariate Analysis
Spirometry
Respiratory Function Tests
Analysis of Variance
Therapeutics
Body Weight
Oxygen
Hypoxia

Keywords

  • CPAP
  • OSAS
  • Overlap syndrome
  • PaO

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Daytime PaO2 in OSAS, COPD and the combination of the two (overlap syndrome). / Lacedonia, D.; Carpagnano, G. E.; Aliani, M.; Sabato, R.; Foschino Barbaro, M. P.; Spanevello, A.; Carone, M.; Fanfulla, F.

In: Respiratory Medicine, Vol. 107, No. 2, 02.2013, p. 310-316.

Research output: Contribution to journalArticle

Lacedonia, D. ; Carpagnano, G. E. ; Aliani, M. ; Sabato, R. ; Foschino Barbaro, M. P. ; Spanevello, A. ; Carone, M. ; Fanfulla, F. / Daytime PaO2 in OSAS, COPD and the combination of the two (overlap syndrome). In: Respiratory Medicine. 2013 ; Vol. 107, No. 2. pp. 310-316.
@article{a0d5bd1f7e954d34bd310980da6a8b14,
title = "Daytime PaO2 in OSAS, COPD and the combination of the two (overlap syndrome)",
abstract = "Background: OSAS and COPD are often associated with day-time hypoxemia. Overlap Syndrome (OS), the association between both diseases, increases the risk of day-time hypoxemia. The aim of this study was to investigate the mechanisms which could justify the low oxygen level and the effect of CPAP. Methods: We performed a retrospective analysis in all patients referred to our institutes for suspected OSAS and who also underwent spirometry and blood gas analysis during our evaluation. Thus, 720 patients were selected. According to pulmonary function test parameters they were divided into 3 groups: OSAS (N = 466,65{\%}); OS (N = 168,23{\%}) and COPD (N = 86,12{\%}). In order to evaluate the differences between the three groups, ANOVA analyses were carried out, whereas a multivariate analysis was performed in order to evaluate which factors determine the diurnal PaO2. In 90 patients we also have the data on blood gas analysis after one year of CPAP treatment, so we evaluate the PaO2 improvement in accordance with compliance to treatment in these patient subgroups. Results: The OS group showed a lower level of daytime PaO2 compared with OSAS patients and T90 was higher in OS compared with OSAS. A multivariate analysis showed that in the OS diurnal PaO2 correlated with age (β = -0.20) and moreover with FEV1 (β = 0.31) and T90 (β = 0.37), while in the OSAS a correlation was found with FEV 1 (β = -0.11) and mostly with BMI (β = 0.25), age and T90. In all patients with good compliance to CPAP day-time PaO2 improved. Conclusions: Our data suggest that day-time hypoxemia in OSA patients is largely determined by the increase of body weight and severity of nocturnal hypoxia. However, CPAP therapy has been shown to improve daytime PaO2 values both in OSAS and in OS.",
keywords = "CPAP, OSAS, Overlap syndrome, PaO",
author = "D. Lacedonia and Carpagnano, {G. E.} and M. Aliani and R. Sabato and {Foschino Barbaro}, {M. P.} and A. Spanevello and M. Carone and F. Fanfulla",
year = "2013",
month = "2",
doi = "10.1016/j.rmed.2012.10.012",
language = "English",
volume = "107",
pages = "310--316",
journal = "Respiratory Medicine",
issn = "0954-6111",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Daytime PaO2 in OSAS, COPD and the combination of the two (overlap syndrome)

AU - Lacedonia, D.

AU - Carpagnano, G. E.

AU - Aliani, M.

AU - Sabato, R.

AU - Foschino Barbaro, M. P.

AU - Spanevello, A.

AU - Carone, M.

AU - Fanfulla, F.

PY - 2013/2

Y1 - 2013/2

N2 - Background: OSAS and COPD are often associated with day-time hypoxemia. Overlap Syndrome (OS), the association between both diseases, increases the risk of day-time hypoxemia. The aim of this study was to investigate the mechanisms which could justify the low oxygen level and the effect of CPAP. Methods: We performed a retrospective analysis in all patients referred to our institutes for suspected OSAS and who also underwent spirometry and blood gas analysis during our evaluation. Thus, 720 patients were selected. According to pulmonary function test parameters they were divided into 3 groups: OSAS (N = 466,65%); OS (N = 168,23%) and COPD (N = 86,12%). In order to evaluate the differences between the three groups, ANOVA analyses were carried out, whereas a multivariate analysis was performed in order to evaluate which factors determine the diurnal PaO2. In 90 patients we also have the data on blood gas analysis after one year of CPAP treatment, so we evaluate the PaO2 improvement in accordance with compliance to treatment in these patient subgroups. Results: The OS group showed a lower level of daytime PaO2 compared with OSAS patients and T90 was higher in OS compared with OSAS. A multivariate analysis showed that in the OS diurnal PaO2 correlated with age (β = -0.20) and moreover with FEV1 (β = 0.31) and T90 (β = 0.37), while in the OSAS a correlation was found with FEV 1 (β = -0.11) and mostly with BMI (β = 0.25), age and T90. In all patients with good compliance to CPAP day-time PaO2 improved. Conclusions: Our data suggest that day-time hypoxemia in OSA patients is largely determined by the increase of body weight and severity of nocturnal hypoxia. However, CPAP therapy has been shown to improve daytime PaO2 values both in OSAS and in OS.

AB - Background: OSAS and COPD are often associated with day-time hypoxemia. Overlap Syndrome (OS), the association between both diseases, increases the risk of day-time hypoxemia. The aim of this study was to investigate the mechanisms which could justify the low oxygen level and the effect of CPAP. Methods: We performed a retrospective analysis in all patients referred to our institutes for suspected OSAS and who also underwent spirometry and blood gas analysis during our evaluation. Thus, 720 patients were selected. According to pulmonary function test parameters they were divided into 3 groups: OSAS (N = 466,65%); OS (N = 168,23%) and COPD (N = 86,12%). In order to evaluate the differences between the three groups, ANOVA analyses were carried out, whereas a multivariate analysis was performed in order to evaluate which factors determine the diurnal PaO2. In 90 patients we also have the data on blood gas analysis after one year of CPAP treatment, so we evaluate the PaO2 improvement in accordance with compliance to treatment in these patient subgroups. Results: The OS group showed a lower level of daytime PaO2 compared with OSAS patients and T90 was higher in OS compared with OSAS. A multivariate analysis showed that in the OS diurnal PaO2 correlated with age (β = -0.20) and moreover with FEV1 (β = 0.31) and T90 (β = 0.37), while in the OSAS a correlation was found with FEV 1 (β = -0.11) and mostly with BMI (β = 0.25), age and T90. In all patients with good compliance to CPAP day-time PaO2 improved. Conclusions: Our data suggest that day-time hypoxemia in OSA patients is largely determined by the increase of body weight and severity of nocturnal hypoxia. However, CPAP therapy has been shown to improve daytime PaO2 values both in OSAS and in OS.

KW - CPAP

KW - OSAS

KW - Overlap syndrome

KW - PaO

UR - http://www.scopus.com/inward/record.url?scp=84872117978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872117978&partnerID=8YFLogxK

U2 - 10.1016/j.rmed.2012.10.012

DO - 10.1016/j.rmed.2012.10.012

M3 - Article

VL - 107

SP - 310

EP - 316

JO - Respiratory Medicine

JF - Respiratory Medicine

SN - 0954-6111

IS - 2

ER -